scispace - formally typeset
Open AccessJournal ArticleDOI

Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

Reads0
Chats0
TLDR
Schizophrenic patients who abuse drugs may represent a subgroup of patients with better prognoses and less severe clinical characteristics of schizophrenia, but their drug abuse may adversely affect global outcome.
Abstract
Objective: This study aimed to 1) determine substance abuse prevalence and preference in a diverse sample ofschizophrenic, schizoaffective, and schizophreniform inpatients, 2) cornpare drug-abusing and non-drug-abusing patients on demographic and clinical variables during the acute and stabilization phases of their hospital course, and 3) obtain data from patients on reasons for drug abuse and on acute state-related changes during periods of intoxication. Method: Eighty-three psychotic inpatients consecutively admitted to a New York City teaching hospital were evaluated. Sixty-eight had schizophrenia, 12 had schizoaffective disorder, and three had schizophreniforrn disorder diagnosed according to the Structured Clinical Interview for DSM-III-R. Each patient received ratings on the Brief Psychiatric Rating Scale, the Global Assessment Scale, and the Scale for the Assessment of Negative Symptoms at admission and at discharge, an evaluation of premorbid adjustment, and an extensive interview on drug and alcohol use. Results: Forty (48%) of the patients received diagnoses of drug or alcohol abuse or dependence. The drug-abusing patients primanly used cannabis (N=26), alcohol (N=2 1), and cocaine (N= I 4) and reported that they abused drugs to get “high, “ to relieve depression, and to relax. They had significantly fewer positive and negative symptoms at discharge, better sexual adjustment and worse school performance during adolescence, and more family histories ofdrug abuse than the non-d rugabusing patients. Conclusions: Schizophrenic patients who abuse drugs may represent a subgroup of patients with better prognoses and less severe clinical characteristics of schizophrenia, but their drug abuse may adversely affect global outcome.

read more

Citations
More filters
Journal ArticleDOI

Models of co-occurring substance misuse and psychosis: are personality traits the missing link?

TL;DR: The current evidence base for three models of co-occurring substance misuse in psychosis are reviewed, and it is suggested that future research examine the inter-relationships between trait and state-specific personality, affective and behavioural variables on co-morbidity.
Journal ArticleDOI

Hallucinations et trouble de personnalité borderline : une revue de littérature

TL;DR: In this paper, the authors explore the concept of reactivite psychotique au stress, impliquant une hyperactivite de l'axe hypothalamo-hypophyso-surrenalien and du systeme dopaminergique, comme modele de l’hallucination dans le TPB.
Journal ArticleDOI

Dual Diagnosis in a State Psychiatric Facility: Risk Factors, Correlates, and Phenomenology of Use

TL;DR: Patients admitted to a state psychiatric facility were interviewed to ascertain the co-occurrence of mental illness and chemical abuse (MI/CA), lifetime substance use, childhood experiences, current living conditions, and use of mental health services.
Book ChapterDOI

Cannabis, Cannabinoids, and the Association with Psychosis

TL;DR: It is likely that cannabis exposure is a “component cause” that interacts with other factors to contribute to the development of schizophrenia or other psychotic disorders, but is neither necessary nor sufficient to do so alone.
Journal ArticleDOI

Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia.

TL;DR: Patients with schizophrenia did not establish a causal link between schizophrenia and the use of cannabis and it is suggested that clinicians consider the findings in their work with patients suffering from these co-occurring disorders.
References
More filters
Journal ArticleDOI

The Brief Psychiatric Rating Scale

TL;DR: The Brief Psychiatric Rating Scale (BRS) as mentioned in this paper was developed to provide a rapid assessment technique particularly suited to the evaluation of patient change, and it is recommended for use where efficiency, speed, and economy are important considerations.
Journal ArticleDOI

The Global Assessment Scale: A procedure for measuring overall severity of psychiatric disturbance.

TL;DR: The relative simplicity, reliability, and validity of the GAS suggests that it would be useful in a wide variety of clinical and research settings.
Journal ArticleDOI

Negative Symptoms in Schizophrenia: Definition and Reliability

TL;DR: The developed Scale for the Assessment of Negative Symptoms has excellent interrater reliability and the five symptom complexes defined by the scale have good internal consistency, which indicates that the conceptual organization of the scale is also cohesive.
Journal ArticleDOI

One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites.

TL;DR: One-month prevalence results were determined from 18571 persons interviewed in the first-wave community samples of all five sites that constituted the National Institute of Mental Health Epidemilogic Catchment Area Program as mentioned in this paper.
Journal ArticleDOI

Measurement of Premorbid Adjustment in Chronic Schizophrenia

TL;DR: The Premorbid Adjustment Scale has been found to be useful in identifying patients likely to become chronically hospitalized or at high risk for readmission, and may also serve as a possible predictor of patients with brain abnormalities on a computerized tomography scan.
Related Papers (5)